SlateStone Wealth’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
VPM
VCM
AM
FAM
SlateStone Wealth's ALAB Position: Q1 2026 in Review
SlateStone Wealth reduced its Astera Labs (ALAB) stake by 86% in Q1 2026, selling an estimated $1.68M and leaving 1,993 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #279.
SlateStone Wealth first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.5M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.
- SlateStone Wealth held 1,993 shares of Astera Labs worth $218K as of Q1 2026.
- SlateStone Wealth sold 11,803 Astera Labs shares in Q1 2026, an estimated $1.68M.
- Astera Labs made up 0.02% of SlateStone Wealth's portfolio in Q1 2026, its #279 holding.
- SlateStone Wealth first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
- SlateStone Wealth's Astera Labs position peaked at $2.5M in Q3 2025.
- 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.
Based on SlateStone Wealth's 13F filing for Q1 2026, filed 14 May 2026.